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Abstract Neutrophil apoptosis is a constitutive process that can
be enhanced or delayed by signals induced by various stimuli. We
investigated the role of phospholipase D (PLD) in neutrophil
apoptosis. The apoptotic rate of neutrophils was found to be
increased by 1-butanol and decreased by the exogenous addition
of PLD. Moreover, the delay of apoptosis by apoptosis-delaying
stimuli such as granulocyte/macrophage colony-stimulating
factor or lipopolysaccharide (LPS) was also blocked by 1-buta-
nol. Unstimulated PLD activity in cultured cells for 20 h was
higher than that in freshly isolated cells and further increased in
cultured cells with LPS. These results suggest that PLD is
involved in the up-regulation of neutrophil survival. + 2002
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The apoptosis of neutrophils has been found to be an im-
portant factor in the resolution of in£ammation [1]. Neutro-
phil-associated functions, such as chemotaxis, phagocytosis,
degranulation, and respiratory burst, are lost when the cells
undergo apoptosis [2,3]. However, aged neutrophils in tissue
exacerbate in£ammation by releasing proteases, reactive oxy-
gen species, and pro-in£ammatory mediators [4]. Therefore,
the modulation of neutrophil apoptosis would be of bene¢t to
patients with decreased numbers of circulating neutrophils
and to those with in£ammatory diseases. Several factors are
known to either suppress or induce neutrophil apoptosis [1,5].
However, the intracellular signaling pathways that underlie
neutrophil apoptosis are still incompletely understood and
controversial.
Phospholipase D (PLD) catalyzes the hydrolysis of phos-
phatidylcholine to generate free choline and phosphatidic acid
(PA). This PA can be further metabolized by phosphatidic
acid phosphohydrolase to form diacylglycerol (DAG) and
by phospholipase A2 to form lysophosphatidic acid. Thus,
PLD appears to amplify the signaling initiated by receptor
activation. When PLD is stimulated in the presence of a pri-
mary alcohol, such as ethanol or 1-butanol, transphosphati-
dylation results in the formation of phosphatidylalcohol in-
stead of PA [6]. Two types of PLD (PLD1 and PLD2) have
been cloned, but they di¡er in terms of their activation and
their subcellular localization [7,8]. Although neutrophil PLD
has not been puri¢ed, it has been shown that the PLD activity
of neutrophils is mainly associated with the plasma mem-
brane, secretory vesicles, and Golgi apparatus [9], and that
it is stimulated by ARF, RhoA, protein kinase C (PKC),
and an unidenti¢ed 50 kDa cytosolic factor [10^12].
The physiological process of neutrophil apoptosis di¡ers
from processes identi¢ed in other cells [1,5]. It is now known
that Lyn, PKC-N, and mitogen-activated protein kinase play a
role in neutrophil apoptosis [13^16]. The involvement of PLD
in the determination of apoptosis has been reported in other
cells, but these results remain contradictory [17]. It has also
been suggested that the inhibition of PLD might be implicated
in the induction of apoptosis by ceramide, since guanosine 5P-
O-(3-thiotriphosphate) (GTPQS)-dependent PLD activity and
the levels of PLD1a and PLD1b were down-regulated in cer-
amide-induced apoptotic glial cells [18]. In addition, PLD ac-
tivation plays an anti-apoptotic role in the hypoxia-induced
cell death of PC12 cells [19]. In contrast to the above results,
PLD activity was upregulated during the apoptosis of Jurkat
T cells, as induced by actinomycin D, tumor necrosis factor
(TNF)-K, or H2O2 [20]. However, the role played by PLD in
neutrophil apoptosis has not been investigated. This study
was designed to determine whether PLD signaling is involved
in neutrophil apoptosis and whether PLD-derived PA plays a
role in the modulation of neutrophil apoptosis.
2. Materials and methods
2.1. Materials
Histopaque, lipopolysaccharide (LPS), dibutyryl-cAMP (dbcAMP),
phorbol 12-myristate 13-acetate (PMA), fMet-Leu-Phe (fMLP), and
bacterial PLD (from Streptomyces chromofuscus) were purchased from
Sigma Chemical Co. (St. Louis, MO, USA), dextran and [3H]1-O-
alkyl-lysophosphatidylcholine (192 Ci/mmol) from Amersham Phar-
macia Biotech (Uppsala, Sweden), granulocyte/macrophage colony-
stimulating factor (GM-CSF) and interleukin-8 (IL-8) from RpD
Systems (Minneapolis, MN, USA), and RPMI 1640 medium from
Gibco-BRL (Rockville, MD, USA). All other reagents and solvents
used were of the highest quality available commercially.
2.2. Cell culture
Peripheral blood neutrophils were isolated from healthy young do-
nors using a method involving dextran sedimentation and di¡erential
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centrifugation through a Ficoll-Hypaque density gradient [11]. Venous
blood was collected on sodium citrate solution (3.8%). The cellular
part of the blood was mixed with a solution of 3% dextran in 0.9%
NaCl solution and kept for 45 min at 25‡C. The neutrophil-rich upper
layer of the suspension was then collected and centrifuged (250Ug,
10 min). Residual erythrocytes were removed by hypotonic lysis and
the pellet so obtained was suspended in HEPES-bu¡ered saline
(25 mM HEPES, pH 7.4, 125 mM NaCl, 0.7 mM MgCl2, and
0.5 mM EDTA). The suspension was centrifuged (250Ug, 30 min)
on Histopaque solution at 4‡C. Isolated neutrophils (2U105/100 Wl)
were maintained in RPMI 1640 medium supplemented with 1% glu-
tamine, 100 U/ml penicillin, and 100 Wg/ml streptomycin in 96-well
£at-bottomed plates at 37‡C in a humidi¢ed atmosphere containing
5% CO2. Neutrophils were shown to be 95% pure morphologically by
microscopy.
2.3. Morphological assessment of neutrophil apoptosis
Neutrophils incubated in the presence or absence of butanol or
various agents were spun down on a glass slide in a cytospin (Shan-
don, PA, USA). Cells were ¢xed with methanol and stained with
Giemsa staining solution. Percentages of apoptotic cells were deter-
mined by counting at least 300 cells per slide.
2.4. Measurement of phosphatidylserine (PS) exposure
PS exposure was measured by the binding of annexin V^£uorescein
isothiocyanate (FITC) using protocol outlined in the TACS apoptosis
detection kit (Trevigen, The Netherlands). Cells (1U106) were ¢rst
harvested and washed with phosphate-bu¡ered saline (PBS). They
are then incubated for 15 min with annexin V^FITC and propidium
iodide (PI). The cells (1U104) were subsequently analyzed with £ow
cytometer (Becton Dickinson, NJ, USA). The combination of annexin
V^FITC and PI allows for the di¡erentiation between early apoptotic
cells (annexin V^FITC-positive), late apoptotic and/or necrotic cells
(annexin V^FITC- and PI-positive), and viable cells (unstained).
2.5. Assay of PLD activity
Neutrophils were labeled with [3H]alkyl-lysophosphatidylcholine
(1.5 WCi/2U107 cells) for 90 min at 37‡C [11], washed twice with
PBS and resuspended in assay bu¡er (20 mM HEPES, pH 7.4,
137 mM NaCl, 2.7 mM KCl, 3 mM MgCl2, 2 mM CaCl2, 1.6%
ethanol, and 1 mg/ml bovine serum albumin). After being incubated
for 20 min at 37‡C in the presence or absence of cytochalasin B and
fMLP or PMA, reactions were stopped by adding 1 ml of CHCl3/
CH3OH/concentrated HCl (50:50:0.3, v/v), and 0.35 ml of 1 M HCl/5
mM EGTA. Lipids were then extracted and separated on Silica gel 60
TLC plates in a solvent system consisting of ethyl acetate/trimethyl
pentane/acetic acid/H2O (13:2:3:10, v/v). The plates were exposed to
iodine vapor and [3H]phosphatidylethanol (PEth) was identi¢ed by its
co-migration with a PEth carrier. Radioactive [3H]PEth was scraped
o¡ the plates and quanti¢ed in a liquid scintillation counter.
2.6. Statistical analysis
Results are presented as meansPS.D. Student’s t-test for unpaired
samples was used to compare means. A probability value of less than
0.05 was considered signi¢cant.
3. Results
Neutrophils rapidly undergo spontaneous apoptosis upon
in vitro culture. Typical apoptotic cells displaying nuclear
condensation and cytoplasmic vacuoles were readily observed
(Fig. 1A). More than 50% of the cells showed apoptotic
changes after 20 h of culture. Culture of neutrophils with
1-butanol for 20 h signi¢cantly increased the number of apo-
ptotic cells (Figs. 1 and 2A). By comparison, no signi¢cant
acceleration of apoptosis was detected after culturing with
secondary alcohol, 2-butanol. Fig. 1B shows original record-
ings of the £uorescence histograms obtained using annexin V
and PI. The £uorescence distribution of freshly isolated neu-
trophils indicates a single cell population. After 20 h of cul-
ture, two £uorescent populations were observed, one contain-
ing annexin V staining and one with normal cells. 1-Butanol
increased annexin V and/or PI staining, indicating that early
Fig. 1. Apoptotic changes of neutrophils by 1-butanol and bacterial PLD. A: Cytospin preparations of neutrophils after incubation in vitro
for 20 h were stained with Giemsa solution. Solid arrows indicate apoptotic cells. Neutrophils were cultured for 20 h with medium (None), 1%
1-butanol (+1-butanol), and 100 units of bacterial PLD (+PLD). B: The cell death was assessed by double staining of cells with FITC-labeled
annexin V and PI. Neutrophils were treated as in A.
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and late apoptotic cells were increased by 1-butanol. When
bacterial PLD (100 units) was exogenously added to the cul-
ture, the spontaneous apoptosis of neutrophils was signi¢-
cantly reduced. As shown in Fig. 2, the e¡ects of 1-butanol
and PLD were dose-dependent. Maximal responses of 1-bu-
tanol and bacterial PLD occurred at 1.5% and 20 units, re-
spectively. Cell necrosis was induced at higher concentrations
of 1-butanol or 2-butanol exceeding 1.5%.
Neutrophils were cultured for 20 h in the presence of GM-
CSF, LPS, dexamethasone, IL-8, and dbcAMP, which are
known to prolong neutrophil survival [1]. As shown in Fig.
3A, all these agents decreased both the number of apoptotic
cells and the extent of DNA fragmentation. The percentage of
apoptotic neutrophils was markedly augmented, by 70%, after
culture with 1-butanol, even in the presence of LPS and GM-
CSF. In contrast, the inhibitory e¡ect of dbcAMP was par-
tially suppressed by 1-butanol. To further characterize
whether PLD-derived PA speci¢cally mediates the inhibitory
e¡ect of PLD on neutrophil apoptosis, cells were pretreated
with propranolol, an inhibitor of phosphatidate phosphohy-
drolase. The treatment of cells with propranolol increased the
number of constitutive apoptotic cells from 50% to 80% (Fig.
3B). Propranolol (20 WM) also signi¢cantly partially blocked
the inhibitory e¡ect of PLD on the apoptosis of neutrophils
(Fig. 3B). However, propranolol failed to block the e¡ect of
GM-CSF, LPS, and IL-8 on neutrophil apoptosis.
Next, we measured PLD activity in cultured neutrophils
with or without LPS or IL-8 for 20 h (Fig. 4). Cultured cells
containing 50% apoptotic cells and 50% aged cells showed
higher basal PLD activity than the freshly isolated neutrophils
(0.70P 0.15% vs. 1.50P 0.15%, P6 0.01). Interestingly, PLD
activity was further increased in cultured cells in the presence
of added LPS or IL-8, and these cells contained fewer apo-
ptotic cells than the untreated incubation, indicating that the
increased PLD activity might be attributed to apoptosis-resis-
tant aged cells. Moreover, the PLD activity of freshly isolated
neutrophils was dramatically increased by 5 WM cytochalasin
B and 1 WM of fMLP or 100 nM of PMA. However, these
agonists failed to further stimulate PLD activity in cells cul-
tured for 20 h with or without LPS or IL-8.
Fig. 2. Dose-dependent e¡ects of 1-butanol and PLD on the sponta-
neous apoptosis of neutrophils. Neutrophils were cultured for 20 h
with increasing concentrations of 1-butanol or 2-butanol (A) and
bacterial PLD (B). Apoptotic cells were identi¢ed by their morphol-
ogy under light microscopy and were counted. Data are reported as
the percentage of cells showing the morphologic features of apopto-
sis. Results represent meansPS.D.
Fig. 3. E¡ects of 1-butanol and propranolol on the delay of neutro-
phil apoptosis. A: Neutrophils were pretreated with or without 1%
1-butanol for 1 h and further incubated for 20 h in the presence of
1 Wg/ml GM-CSF, 1 Wg/ml LPS, 300 WM dibutyryl-cAMP, 5 WM
dexamethasone, and 100 ng/ml IL-8. B: Neutrophil were pretreated
with 10 WM propranolol for 1 h and further incubated for 20 h in
the presence or absence of bacterial PLD (20 units), GM-CSF, LPS,
and IL-8. Data are reported as the percentage of cells showing mor-
phologic features of apoptosis. Results represent meansPS.D.
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4. Discussion
PLD-derived PA is well known for its role in cell prolifer-
ation, but its role in non-proliferating and terminally di¡er-
entiated cells like neutrophils has not been fully investigated.
Cellular responses induced by exogenously added PA might
di¡er from the responses evoked by intracellular PA, since
neutrophils have speci¢c binding sites for PA, the occupation
of which leads to the mobilization of intracellular Ca2þ [21].
Thus, we did not consider the e¡ect of exogenously added PA
on neutrophil apoptosis. In the present study, incubation with
PLD was signi¢cantly more potent than incubation with the
other tested agents in terms of inhibiting neutrophil apoptosis.
In neutrophils where endogenous PA and DAG formation
was prevented by 1-butanol treatment, apoptosis increased.
Similar apoptotic-inducing actions of 1-butanol have been
observed in other cells [19]. However, there is a possibility
that acute treatment of neutrophil suspension with 1% buta-
nol can induce apoptosis by a mechanism other than inhibi-
tion of PLD and PA accumulation. It has been shown that
ethanol induces the apoptosis of neutrophils by production of
nitric oxide [22] and that ethanol-induced apoptosis of liver
cells is initiated by the intracellular Ca2þ elevation in the
cytoplasm [23]. However, the treatment of neutrophils with
1-butanol did not produce nitric oxide (results not shown).
Furthermore, Nw-nitro-L-arginine methyl ester, an inhibitor
of nitric oxide synthase, and EGTA, a calcium chelator, did
not attenuate 1-butanol-induced apoptosis (results not
shown).
One should be careful to interpret the e¡ect of PLD on
cellular responses, including apoptosis, since PA is further
metabolized to DAG, which is an activator of PKC. The
propranolol-mediated inhibition of DAG generation may
have an in£uence on the apoptosis of neutrophils and may
be comparatively more potent than PA in the induction or
inhibition of apoptosis. The ¢nding that the PLD-induced
delay of apoptosis was partially inhibited by propranolol sug-
gests that PA-derived DAG may be involved in the apoptotic
process of neutrophils. Kanaho et al. [24] reported that etha-
nol signi¢cantly inhibited the chemoattractant-stimulated de-
granulation of neutrophils but that propranolol had no e¡ect
on degranulation. There is also a possibility that a metabolite
of PA, other than DAG, might also induce apoptosis.
The apoptosis of neutrophils is modulated by various fac-
tors, including in£ammatory mediators like GM-CSF, IL-8,
and TNF-K [1,5]. However, it is unknown how these factors
in£uence the lifespan of neutrophils. We can speculate that
delay of apoptosis by GM-CSF, LPS, and IL-8 is mediated by
PLD activation, since all these agents can modulate PLD
activity. Moreover, the addition of GM-CSF primes PLD to
subsequent stimulation by fMLP or PMA [25], and GM-CSF
stimulated PLD activity in adherent neutrophils [26]. LPS and
IL-8 stimulate PLD activity, whereas cAMP down-regulates
PLD activity [27,28]. The majority of priming and activating
agonists of neutrophils functions, including PLD activity, in-
hibit or accelerate apoptosis. On the other hand, corticoste-
roids and cAMP-elevating agents induce apoptosis in thymo-
cytes and lymphocytes, but have the opposite e¡ects in
neutrophils [29,30]. However, the anti-apoptotic e¡ects of
LPS and GM-CSF were blunted by 1-butanol in our experi-
ment, which suggests their anti-apoptotic role may be associ-
ated with the PLD pathway. In contrast, the anti-apoptotic
e¡ect of cAMP was not a¡ected by 1-butanol as much as it
was by the other agonists. Our group has shown that GTPQS-
stimulated PLD activity is inhibited by protein kinase A
(PKA) [31]. However, PKA is unlikely to mediate the e¡ect
of cAMP on neutrophil apoptosis because H-89, an inhibitor
of PKA, did not prevent the inhibition of apoptosis by
dbcAMP [32]. Although the exact target site(s) has to be iden-
ti¢ed, these ¢nding suggests that di¡erent mechanisms are
active in the modulation of neutrophil apoptosis by cAMP.
Upon appropriate conditions, neutrophils are capable of pro-
ducing and releasing GM-CSF or IL-8, which are potent in-
hibitors of apoptosis. Therefore, it is speculated that 1-buta-
nol may a¡ect this process. However, 1-butanol-induced
neutrophil apoptosis was not blocked by preincubating with
or the simultaneous addition of GM-CSF and IL-8 (results
not shown).
It has been demonstrated that functional activities, includ-
ing degranulation and generation of O32 , in response to exter-
nal stimuli decline as neutrophils proceed through apoptosis
[2,33,34]. PLD activity in cultured cells was higher than in
freshly isolated cells, indicating that apoptotic cells appear
to have a more active PLD status than aged cells. These
results may be in agreement with a previous report, which
showed an increased PLD activity during the H2O2-induced
apoptosis of PC12 cells, and during the apoptosis of Jurkat T
cells, as induced by TNF-K or H2O2 [19,20]. However, care is
needed to interpret PLD activity changes in the apoptotic
process since both apoptotic and aged cells are present simul-
taneously. Interestingly, in the present study, PLD activity
was further increased in cultured cells, which contained fewer
apoptotic cells, by treatment with LPS or IL-8. This result
suggests that the increment of PLD activity in 20 h cultured
cells may be due to the basal activity of aged cells, rather than
from apoptotic cells. It was also reported that the PLD activ-
ity of HL-60 cells is not signi¢cantly changed during the ap-
Fig. 4. Changes of PLD activity in neutrophils containing apoptotic
cells. PLD activity was measured from freshly isolated neutrophils
(Fresh), 20 h cultured cells in culture medium (20hr/None), 20 h
cultured cells with IL-8 (20hr/IL-8), and 20 h cultured cells with
LPS (20hr/LPS). Reactions were initiated by addition of mock
(None), 5 WM cytochalasin B and 1 WM fMLP (fMLP), or 100 nM
PMA (PMA). After 20 min, the incubations were terminated and
formation of PEth was quanti¢ed as described in Section 2. Data
represent meansPS.D. *P6 0.01, fresh cells vs. 20 h cultured cells
with medium. **P6 0.01, 20 h cultured cells with medium vs. 20 h
cultured cells with LPS or IL-8.
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optotic process [20]. It has been shown that PLD1 has low
basal activity but PLD2 is constitutively active [7,8]. The high
basal levels of PLD activity observed in aged cells might be
due to increased expression of PLD2. Yoshimura et al. [18]
showed PLD2 expression is increased in apoptotic cells,
whereas the level of PLD1 mRNA is down-regulated. Un-
fortunately, progress in identifying the changes of PLD ex-
pression in neutrophil apoptosis has been hampered by the
failure to purify the enzyme(s) to homogeneity and to detect
the level of PLD isotypes exactly using commercially available
anti-PLD antibodies. Thus, we performed reverse-transcrip-
tase-mediated polymerase chain reaction to compare mRNA
levels of PLD1 and PLD2 in freshly isolated cells and cells
cultured for 20 h with or without LPS or IL-8. However,
mRNA levels of PLD1 and PLD2 were not correlated with
PLD activities (results not shown). Regardless of the changes
in the PLD protein itself, PLD activity may be implicated in
the process of apoptosis since butanol, propranolol, and exog-
enous PLD a¡ect apoptotic rate.
On the other hand, 1-butanol caused DNA fragmentation,
showing strong PI staining. This indicates that activation of
endonuclease occurred. Caspase-3 activity was identi¢ed in
neutrophils undergoing apoptosis [35]. In addition, actin and
fodrin are substrates for caspases [36,37] and inhibit PLD
activity [38,39]. Therefore, it is plausible that caspase activa-
tion leads to the degradation of actin and fodrin, and that this
results in an amelioration of the inhibition of PLD activity.
In summary, this study shows that the elevation of the
intracellular level of PA, formed by adding exogenous PLD,
inhibits spontaneous apoptosis, which suggests that the PLD
pathway is one of signaling events in the modulation of neu-
trophil apoptosis.
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